Label: LORATADINE tablet

  • NDC Code(s): 70010-162-01, 70010-162-34
  • Packager: Granules Pharmaceuticals Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated January 27, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT(S)

    Loratadine 10 mg

  • PURPOSE

    Antihistamine

  • USE(S)

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

     runny nose


     sneezing

     itchy, water eyes

     itching of the nose or throat

  • WARNINGS

    DO NOT USE

    if you have ever had an allergic reaction to this product or any of its ingredients

  • ASK A DOCTOR BEFORE USE IF

    you have liver or kidney disease. Your doctor should determine if you need a different dose.

  • WHEN USING THIS PRODUCT

    do not take more than directed. Taking more than directed may cause drowsiness.

  • STOP USE AND ASK DOCTOR IF

    an allergic reaction to this product occurs. Seek medical help right away.

  • PREGNANCY/BREASTFEEDING

    ask a health professional before use

  • KEEP OUT OF REACH OF CHILDREN

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • DIRECTIONS

    adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours
    children under 6 years of age ask a doctor
    consumers with liver or kidney disease ask a doctor

  • OTHER INFORMATION

    Tamper-evident: do not use if foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken


    Blister Foil Units

    safety sealed: do not use if the individual blister unit is open or torn

  • STORAGE

    store between 20º to 25ºC (68º to 77ºF)

  • INACTIVE INGREDIENTS

    Lactose monohydrate, magnesium stearate, sodium starch glycolate and starch maize pregelatinized

  • QUESTIONS OR COMMENTS

    Contact 1-877-770-3183 Mon-Fri 9:00 AM to 4:30 PM EST.

  • PRINCIPAL DISPLAY PANEL

    loratadine-10mg-containerlabel-jpg.jpg

  • INGREDIENTS AND APPEARANCE
    LORATADINE 
    loratadine tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70010-162
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    Product Characteristics
    Colorwhite (White to off white) Scoreno score
    ShapeROUNDSize6mm
    FlavorImprint Code G;10
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70010-162-01100 in 1 BOTTLE; Type 0: Not a Combination Product11/17/2021
    2NDC:70010-162-34300 in 1 BOTTLE; Type 0: Not a Combination Product05/01/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21072201/01/2020
    Labeler - Granules Pharmaceuticals Inc. (079825711)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!